Video Experimental Relacionado

Updated: Feb 26, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

Un estudio de co-diseño para desarrollar una intervención prototipo temprana para apoyar el uso de medicamentos

Yejin Seo¹, Karen Suchanek Hudmon¹, Kellie Jones Weddle¹

¹College of Pharmacy, Purdue University, West Lafayette, IN, USA.

Patient preference and adherence

|February 25, 2026

Resumen

Pacientes co-diseñaron intervenciones para el manejo de medicamentos anticancerosos orales (MCAO) para el cáncer de mama. Los prototipos incluyen un manual y una aplicación para mejorar la adherencia a los MCAO y el apoyo al paciente.

Área de la Ciencia:

Oncología
Atención centrada en el paciente
Informática de la salud

Sus antecedentes:

El cáncer de mama es una de las principales causas de muerte en mujeres.
Los medicamentos anticancerosos orales (MCAO) aumentan la responsabilidad del paciente en el manejo.
La falta de apoyo adecuado al paciente para los MCAO es una preocupación creciente.

Objetivo del estudio:

Co-diseñar un prototipo de intervención en etapa temprana.
Apoyar a las pacientes con cáncer de mama en el manejo de los MCAO.
Utilizar un enfoque de diseño participativo centrado en el paciente.

Principales métodos:

Se llevaron a cabo sesiones de diseño participativo (DP) con cinco pacientes con cáncer de mama en tratamiento con MCAO.
La DP involucró etapas de inspiración, ideación y convergencia.
Las pacientes identificaron desafíos y co-desarrollaron soluciones.

Principales resultados:

Los desafíos clave incluyeron el manejo de efectos secundarios y la navegación de recursos.
Se generaron diez soluciones, lo que llevó a dos prototipos prioritarios: un manual y una aplicación de navegación.
Los pacientes favorecieron la usabilidad del manual y las características de comunicación de la aplicación.

Conclusiones:

Involucrar a los pacientes como co-diseñadores es valioso para el desarrollo de intervenciones.
Ambos prototipos de manual y aplicación muestran potencial para mejorar la adherencia a los MCAO.
Los hallazgos ofrecen información para futuras intervenciones de apoyo a medicamentos anticancerosos orales.

Palabras clave:

cáncer de mama adherencia a la medicación manejo de la medicación diseño participativo resultados centrados en el paciente

Más Videos Relacionados

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

Videos de Conceptos Relacionados

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Dosage Regimens: Designs and Approaches

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...